/Companies

Basecamp

London, GB · Founded 2019 · 73 employees on LinkedIn · 17 known investors

Find your way into Basecamp

Sign up to see every warm intro you have to Basecamp

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Basecamp team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A new type of biodiscovery, discovering and harnessing nature's most valuable proteins

Also known as Basecamp Research · BCR

Founders & leadership

Basecamp was founded in 2019 by Oliver Vince and Glen Gowers.

OVOliver Vince
Oliver VinceFounderHe holds a PhD in biomedical engineering from the University of Oxford, where he also tutored undergraduates in the Department of Engineering Science and worked as an R&D engineer with the university's iGEM team. He led the Return to Vatnajökull expedition and previously served as president of Engineers Without Borders Oxford.
GGGlen Gowers
Glen GowersFounderHe completed a PhD in synthetic biology at Imperial College London and served as scientific lead on the Return To Vatnajökull Expedition, which he joined after co-founding a research team at Oxford University's iGEM programme. He also spent time in corporate strategy at Silence Therapeutics.
GG
Glen Gowers Oliver VinceFounder

Investors · 17

SYSTEMIQreportedLondon

How we know: the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

André HoffmannFeike SijbesmaPaul Polman

Funding

SEC filings, press & company announcements

$140M disclosed across 1 of 2 rounds · 2024–2026

Source: company announcements and press reports — follow each round's link for the claim.

Valuation · disclosed

Disclosed events
$800MvaluationSep 2026
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Company profile

researched Aug 2026

Basecamp Research is a UK-based company that applies artificial intelligence to biological systems design, positioning its work as exploring biology beyond what is captured in existing public reference databases. It collects biodiversity-derived genetic data and organises it into a proprietary foundational dataset and knowledge graph, which it uses to identify and refine novel proteins matched to specific applications for partner organisations.

The company's product framework, BaseGraph, is described as a generation of AI-based design built on a high-resolution map of global genetic biodiversity. By capturing the genetic, evolutionary and environmental context of each protein, the company states it can design proteins tailored to particular industrial, therapeutic or diagnostic uses without running directed evolution campaigns. Its stated commercial focus is business-to-business work with partners in the biopharma and wider bioscience ecosystem rather than public-facing products.

Founding story

Basecamp Research was founded in the United Kingdom by Glen Gowers and Oliver Vince. Gowers serves as co-founder and CEO.

Business model

The company works through commercial bioscience partnerships, applying its dataset and AI design capabilities to identify and optimise proteins for partners' specified industrial, therapeutic and diagnostic applications.

Traction

As of October 2024 the company reported 15 commercial bioscience partnerships across a range of industries and total funding of $85 million.

Latest developments

In October 2024 Basecamp Research announced a $60 million Series B led by Singular, appointed biotech executive Anupama Hoey as Chief Commercial Officer, and entered a multi-year collaboration with the laboratory of David R. Liu at the Broad Institute of MIT and Harvard focused on approaches to programmable genetic medicines.

▸Full profile — market position, technology, go-to-market, geography

Market position

The company is described in press coverage as a participant in mapping biodiversity for AI-based design of biological systems, with its approach compared to protein-structure work such as DeepMind's AlphaFold 2.

Technology

Basecamp Research builds a foundational biological dataset reported to contain 100 times more advanced biological systems than the public databases most commonly used by pharmaceutical researchers. This underpins BaseGraph, a knowledge graph and AI design system built on a high-resolution map of global genetic biodiversity. Capturing the genetic, evolutionary and environmental context of each protein is presented as the basis for designing application-specific proteins without directed evolution campaigns. Proceeds from the 2024 Series B were earmarked for scaling data collection, expanding computing capacity and developing a further generation of foundational models.

Go-to-market

Partners in biopharma and other bioscience-adjacent industries seeking proteins for industrial, therapeutic or diagnostic applications.

Geography

Founded and based in the United Kingdom.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Commercial bioscience partnershipsOct 202415 partnerships
Total funding raised to dateOct 2024$85M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 1

Companies working in the same space as Basecamp.

Timeline · 3

launches, deals, and filings
Oct 2024
Basecamp Research raises $60M Series B led by Singular

The company secured a $60 million Series B financing led by Singular, with S32, redalpine, André Hoffmann, Feike Sijbesma, Paul Polman and returning investors True Ventures and Hummingbird Ventures participating. Proceeds are directed to scaling data collection, computing and new foundational models.

$60M source ↗

Oct 2024
Anupama Hoey appointed Chief Commercial Officer

The company added biotech executive Anupama Hoey as Chief Commercial Officer, reported with more than 20 years of leadership experience and biopharma deals worth more than $5 billion.

source ↗

Oct 2024
Multi-year collaboration with the Liu Lab at the Broad Institute

Basecamp Research entered a multi-year collaboration with the laboratory of Dr. David R. Liu at the Broad Institute of MIT and Harvard to advance approaches to programmable genetic medicines.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

▸Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Basecamp do?
Basecamp Research is a UK AI biotech mapping global genetic biodiversity to design proteins for industrial, therapeutic and diagnostic uses.
Who founded Basecamp?
Basecamp was founded by Oliver Vince, Glen Gowers in 2019.
Who are Basecamp's investors?
Basecamp's investors include Blue Horizon Corporation, Hummingbird Ventures, NVentures, NVIDIA, S32, Section 32, Systemiq Capital, True Ventures and 6 more.
How much funding has Basecamp raised?
Basecamp has disclosed $140M raised across 1 of its 2 known rounds.
Where is Basecamp headquartered?
Basecamp is headquartered in London, GB.